article thumbnail

Coherus sets steep discount for Humira copycat, plans direct sales

Bio Pharma Dive

The biotech will price its biosimilar Yusimry at 85% below Humira’s list price when it launches next month, and charge even less if bought through Mark Cuban’s pharmacy.

Sales 305
article thumbnail

Court rules for drugmakers in 340B fight over contract pharmacies

Bio Pharma Dive

The drugmakers sued HHS after regulators ordered them to stop restricting sales of 340B drugs to contract pharmacies. The decision is a win for Sanofi, Novo Nordisk and AstraZeneca.

Pharmacy 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

pharmaphorum

Sam Crowther, founder and CEO of cybersecurity company Kasada, tells us about a recent discovery his company made that revealed tens of thousands of accounts with prescription drug attachments in major online pharmacies had been compromised. Detection of fraudulent activity. “The [implications of these stolen accounts] are twofold.

Pharmacy 138
article thumbnail

Leading retail pharmacies in pharma

Pharmaceutical Technology

Increasing diagnosis of chronic diseases is expected to lead to fast growth in retail pharmacies. The rising incidence of long-standing diseases such as hypertension, diabetes, cardiovascular diseases, and cancer requires prolonged medication and, thus, drives the growth and need for retail pharmacies in the market. Speciality care.

Pharmacy 113
article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

Research shows that the three-drug companies that dominate global insulin sales — Novo Nordisk, Eli Lilly, and Sanofi may not be entirely to blame for the soaring costs to people with diabetes. Gross profit from PBM-owned mail-order, and specialty pharmacies increased more than 13 percent, from $8.9 Los Angeles Times. billion to $5.7

Insulin 240
article thumbnail

MHRA bans OTC sale of codeine after recreational abuse reports

Pharmaceutical Technology

Codeine linctus has been reclassified from a pharmacy-only medicine to a prescription-only medicine in the UK.

Sales 130
article thumbnail

McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses

NY Times

Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.

Pharmacy 145